Answer:
Bacteria are highly adaptable microorganisms who have the capability of developing defense mechanisms against that which may harm them. Not least important of all, is the easiness with which some bacteria, especially pathogenic bacteria like Salmonella, or Klebsiella, develop mechanisms of resistance to antiseptics and, most importantly, antibiotics.
Antibiotics are a chemical substance that was created, and has been developed, in order to be able to combat pathogenic microorganisms, specifically bacteria. However, because today these substances are being used indiscriminately, we are now seeing a very worrying pattern of antibiotic-resistance patterns in microorganisms that used to be sensible to them. The result, we are facing strains of pathogenic bacteria, like Klebsiella pneumonia and E. Coli, that have become resistan to all types of antibiotics, from first generation, to fourth generation. And this has meant that when people acquire infection by these pathogens, the likelihood of death by them has increased because there are no agents capable of combating them.
Exposure to antibiotics has been the sole reason why these resistant strains of bacteria have emerged, especially when these antibiotics are not necessary. And feeding these substances to animals, to ensure their development and weight gain, has not made the situation any better. Now, we are instead adding also bacteria to the list that did not use to be resistant, but that are becoming so as they become adjusted to the constant exposure to antibiotics. Again, the result has been: more people infected with bacterial strains that cannot be combated with any of the existing antibiotic agents.
Based on the information we have, we can confirm that when Simon is looking for the bottle containing pleural fluid, he should gravitate towards the bottle with a clear or slightly yellow liquid.
<h3>Why should he choose this bottle?</h3>
Simon is looking for pleural fluid. This means that he is looking to find a bottle with a sample of the fluid used by the lungs to allow breathing to take place. This liquid is described as a clear or slightly yellow-colored liquid.
Therefore, we can confirm that when Simon is looking for the bottle containing pleural fluid, he should choose the bottle with a clear or slightly yellow liquid.
To learn more about the lungs visit:
brainly.com/question/271268?referrer=searchResults
Answer:
Hello!
Explanation:
I hope you are doing good. Have a noice day .
Answer:
Heart failure is frequently the cause. Pressures in the heart rise when a sick or overworked left ventricle can't pump out enough of the blood it receives from the lungs. Fluid is pushed past the blood vessel walls and into the air sacs by the increasing pressure.
A Drug Trend report published in 2009 had predicted continued price increase among traditional branded and biotech drugs that lack generic competition. Now, further, CMS has reduced its Average Sales price (ASP) margin from 6 percent to 4 percent for non-pass-thorough. This has affected pharmacy reimbursement. However, there are certain other aspects of Pharmacy Billing that can affect reimbursement and thereby the Revenue Cycle Management (RCM) process if not well implemented.
1. Data Workflow:
Recognizing how the revenue cycle works in pharmacy is very essential. Procurement to Inventory, billing and reimbursement involves purchase of medications, their storage, and method of dispensing, how they are administered, way they are coded & billed, and finally reimbursed. If the drug is covered as a pharmacy benefit, or the payer needs that to be obtained via a specialty pharmacy as identified through patient-specific benefit verification, then here both the provider and the pharmacy are part of the reimbursement process. The physician writes a prescription and orders the drug. This is followed by the pharmacy that fills the order and issues the drug to the physician, CMHC, or hospital outpatient department. Here the pharmacy bills the insurance company for the drug. If any information is entered incorrectly into the pharmacy system in the initial phase of the cycle, errors can prove to be costly, impacting aspects of clinical and revenue cycle.
2. Procurement:
During this phase information is converted from purchased quantities and pricing to storage units of measure (UOM) and inventory costs. Manually entering the data is followed in most cases. UOM conversions, when data is uploaded from the wholesale distributor to the pharmacy system, are also checked and verified manually. Here too mistakes can lead to breakdown in the revenue cycle management (RCM) process.
3. The Charge master:
Critical & substantial revenue leakage can occur when separately reimbursable medications are either missing from or miscoded in the charge master. Conversion of pharmaceutical quantities is a must from purchased amounts to patient-administered amounts, and only then made billable. There is often a difference between dosage amounts required for patient use as from that purchased. Besides inventory, the clinician and pharmacist should convert dosage, strength, and delivery mechanism for each drug. Drug data must be correctly converted from the quantities residing in clinical systems into the payer-billable quantities appropriate for the financial system or charge master. The UOMs must be reconciled to avoid any under- or over-payments. More than often, missing or incorrect data in the charge master can result in negative financial consequences – denied claims, partial reimbursement, and compliance risks.
4. Linkages between Purchases & Billing:
Most hospitals have separate processes to order drugs, administer them, and process reimbursement. Without linkage between pharmacy expenditures for medications (i.e., spend data) and the charge master, ensuring proper charge capture and optimal reimbursement is a challenge. Besides hospitals should have automated tools to identify charge capture errors precisely, so as to pinpoint when and where their occurrence to decreasing revenue loss.
